Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Active, Not Recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations
  • LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • UC Health Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT06378177

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
  • Fujian cancer hospital Fuzhou, Fujian, China
View all 16 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

NCT05172258

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

NCT06295731

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Medical Oncology Associates of San Diego San Diego, California, United States
View all 87 locations
View Trial Details

Related conditions